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A HIGH incidence of mixed cervical carcinomas, containing both a squamous
and a columnar component, during and after pregnancy as compared with non-
pregnant pre- and postmenopausal women (Cherry and Glucksmann, 1961) sug-
gested that hormonal factors may influence the type of a tumour developing
during a pregnancy. In order to put this hypothesis to an experimental test, the
female genital tract of rats was treated with carcinogenic chemicals and the endo-
crine status of the animals was altered experimentally (Glucksmann and Cherry,
1958; Cherry and Glucksmann, 1960). The majority of the tumours induced in
the rat were sarcomas and while the endocrine status did affect the induction
time and the yield of tumours, the influence of the hormonal treatment on the
resulting tumour type could not be ascertained since the tumours were sarcomas
rather than carcinomas.
In mice carcinomas have been induced experimentally by the application of
sex hormones (Allen and Gardner, 1941 ; Pan and Gardner, 1948; Gardner, 1959)
and by the local application of chemical carcinogens of various types (Murphy,
1953, 1961; v. Haam and Scarpelli, 1955; Scarpelli and v. Haam, 1957; Reagan,
Wentz and Machicao, 1955; Krieg and Reagan, 1961; Koprowska, Bogacz,
Pentikas and Stypulkowski, 1958; Koprowska and Bogacz, 1959; Bogacz and
Koprowska, 1961 ; Boyland, Charles and Gowing, 1961 ; Klavins and Kaufmann,
1962; Barbieri, Olivi and Paoletti, 1961; Wachtel, 1961). Most of the tumours
were squamous cell carcinomas, though a few mucin-producing carcinomas were
also found as well as a small number of sarcomas (Murphy, 1961). Some of
these investigators have usedhormonal changes as well as carcinogens andreported
an effect of castration and of subsequent treatment with oestrogens on the in-
duction time and yield of tumours (Murphy, 1961; Krieg and Reagan, 1961;
Pan and Gardner, 1948; Jackson and Robson, 1957; Hall, Balder and Hamilton,
1953; Perry and Ginzton, 1937) but not on the type of the tumour. Similarly
effects of castration and additional hormonal treatments have been reported for
breast tumours in rats and mice (Huggins, Briziarelli and Sutton, 1959; Geyer,
Bryant, Bleisch, Peirce and Stare, 1953; Cantarow, Stasney and Paschkis,
1948), the skin ofmice (Marchant, 1959) andthe vagina ofrats (Cherry and Glucks-
mann, 1960; Glucksmann and Cherry, 1958). Shay, Harris and Gruenstein (1952)
reported that following gastric installation of methylcholanthrene, castration
and additional steroid application, mammary glandular tumours predominated
in females and in males given oestradiol, spindle cell tumours and mesenteric
sarcomas in males and in females given testosterone, while fibroadenomas of theCERVICAL AND VULVAL TUMOURS IN MICE
breast occurred in castrated males and females. The present investigation was
devised specifically to test whether the development ofsquamous and ofcolumnar
carcinomas could be influenced by hormonal factors.
MATERIAL AND METHODS
Female C3H and Strong A mice 8-12 weeks old were used for the experi-
ments. Intact and castrated animals were painted intravaginally once weekly
with a 1 per cent solution in acetone of 9, 10-dimethyl-1,2-benzanthracene
(DMBA) obtained from Messrs. L. Light & Co. The vagina was stretched open
by dorsal flexion of the tail, a cotton wool swab on the end of a thin wire was
inserted and the cervix and vagina painted by means of a rotary motion. In
all the experiments the vulva was blotted with filter paper immediately after the
painting to reduce contamination by the carcinogen.
Bilateral ovariectomy was performed under ether or nembutal anaesthesia
on mice 4-8 weeks old, and the painting was started 1-4 weeks later. Groups of
castrated mice received additional hormone treatment which was started a few
days before the first vaginal painting.
The various experimental procedures are given in Table I in which only mice
surviving for at least 75 days after the beginning of DMBA treatment are con-
sidered as " at risk ".
Stilboestrol was used for oestrogenic stimulation and added daily in a con-
centration of 20 ltg. to the drinking bottles containing 200 c.c. of water. This
dose was sufficient to restore the volume and cellularity of the atrophic castrate
uterus to the state of the intact animal. In experiments on rats a similar con-
centration ofstilboestrol was equivalent in its effect to the intramuscular injection
of 2 x 1 ,ug. of oestradiol monobenzoate per week. The implantation of oestra-
diol-cholesterol pellets was avoided since it caused pyometra in the rats and
death from purulent endometritis. Furthermore, in the control experiments the
implantation of cholesterol pellets was found to influence the induction period
and yield of tumours in rats and for this reason the simple method of oestrogenic
stimulation by the addition of stilboestrol to the drinking water was chosen.
Progesterone (Organon Ltd.) was injected intramuscularly twice weekly in a
dose of 0-2 mg. in one experiment while in another it was administered in the
form of Lutocyclin M crystules (CIBA). The Lutocyclin was implanted sub-
cutaneously in a dose of 50 mg. at the beginning of the experiment followed 2
months later by an implantation of 25 mg. and after a further 6 weeks by another
dose of 25 mg.
L-Thyroxine sodium (Eltroxin, Glaxo) was added to the drinking water in a
concentration of 0*01 mg. per 100 c.c. of water daily and in addition a dose of
3 Itg. in Tyrode was injected intramuscularly once weekly.
Animals were killed when the presence of vaginal or cervical tumours was
indicated by their prolapse or by bleeding on painting or when extensive vulval
tumours or other conditions (mammary carcinoma or leukaemia) likely to cause
death or suffering, required it. At autopsy, apart from other organs or tissues
showing abnormalities, the uterus, cervix, vagina, vulval skin, adrenals and, in
intact mice, the ovaries were fixed routinely in Zenker-acetic, dehydrated and
embedded in paraffin and sectioned at 8 ,t. Except for large cervical and vaginal
tumours, the halved blocks of cervicovaginal tissue were cut serially. Sections
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were stained with haematoxylin-eosin, by the periodic acid-Schifftechnique (PAS)
with or without previous diastase digestion, with Southgate's mucicarmine stain,
with van Gieson's stain or with a modified " Azan " stain.
RESULTS
Carcinoma induction in the cervix and vagina
Intravaginal painting with DMBA of intact mice induced invasive carcinomas
ofthe cervix or vagina in 13 ofthe 17 (76 per cent) animals atrisk. These tumours
usually involved the cervix and in many cases extended on to the vagina but in
a few animals the growth was confined to the vagina. Only squamous cell car-
cinomas were found in the intact mice and the majority were well differentiated
with good keratinisation and the formation of horn pearls (Fig. 1). A few of
the tumours were more anaplastic and produced little keratinisation and few
horn pearls.
Treatment with DMBA induced carcinomas ofthe cervix or vagina in 8 of the
15 (53 per cent) castrated animals at risk. Ofthese tumours 5 were ofthe squam-
ous cell type while the remaining 3 were mixed carcinomas giving an incidence
of 38 per cent of all cancers in this group (Table I). In these mixed tumours
TABLE I.-Induction of Cervical Carcinomas in Mice by
Local Application of DMBA
Mice Percentage
-, Percentage of mixed
Number of carcinomas of
'l'reatment Strain at risk carcinomas all carcinomas
Intact mice . . C3H 17 76 0
Castrate mice . C3H 15 53 38
+ Stilboestrol A 21 . 62 0
+ Progesterone C3H 16 . 81 31
+ Lutocyclin A 16 75 42
+ Eltroxin . . C3H 13 . 61 12
columnar mucin-producing as well as keratinising squamous components were
present in separate foci or in the same tumour strand (Fig. 2-5). Both tumour
strains showed definite malignant characteristics in their cytology and structure
and could be distinguished easily from persisting normal mucin-secreting cells
or glands surrounded by squamous celled carcinomas (Reagan et al., 1955).
EXPLANATION OF PLATE
FIG. 1.-A keratinising squamous cell carcinoma ofthe cervix ofan intact C3H mouse induced
by weekly paintings with DMBA over a period of 196 days. H. E. x 85.
FIG. 2.-A mucoepidermoid carcinoma of the cervix in a castrate C3H mouse induced bv
weekly paintings with DMBA over a period of 178 days (cf. also Fig. 3-5). At the endo-
cervical end the tumour is predominantly adenocarcinomatous (cf. Fig. 4), followed by a
region consisting of squamous cell carcinoma (cf. Fig. 3) which in turn is followed by solid
formations of mucin-secreting tumour cells (cf. Fig. 5). P.A.S. x 14.
FIG. 3.-Part of the keratinising squamous cell carcinoma in Fig. 2. P.A.S. x 110.
FIG. 4.-Part of the adenocarcinomatous formation in Fig. 2. The black regions represent
mucin secretion in the glandular formations. P.A.S. x 150.
FIG. 5.-The mucoepidermoid portion of the tumour in Fig. 2 has cells of squamous shape
arranged in epithelial strands but containing mucin which appears as the intenselv black
cytoplasmic regions. P.A.S. x 110.
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DMBA painting ofcastrated mice given stilboestrol per os induced carcinomas
of the cervix or vagina in 13 of the 21 (62 per cent) animals at risk. As in the
intact mice all these tumours were squamous cell carcinomas most of which were
well differentiated.
DMBA painting of castrated mice given progesterone by intramuscular in-
jection induced carcinomas ofthe cervix or vagina in 13 of 16 (81 per cent) animals,
and when the hormone was given as Lutocyclin crystules in 12 of 16 (75 per cent)
mice. In both groups mixed tumours as well as squamous cell cancers were
found. With the intermittent hormonal stimulation 4 of the 13 tumours (31
per cent) were mixed carcinomas while with the continuously acting Lutocyclin
crystules 5 of the 12 cancers (42 per cent) were of this type (Table I). These
mixed tumours contained separate squamous (Fig. 3) and columnar foci (Fig. 4)
as well as some areas in which the two cell strains were intermingled (Fig. 5).
The adenocarcinomatous element was more extensive with additional progesta-
tional stimulation than in the mixed tumours of the castrate mice where they
were found only after prolonged search in serial sections.
In the castrates given Eltroxin, painting with DMBA induced carcinomas of
the cervix or vagina in 8 of the 13 (61 per cent) mice at risk. Of these tumours
7 were of the squamous cell type and 1 was a mixed carcinoma (Table I). One
ofthe mice had a leiomyosarcoma extending from the cervix to the uterus as well
as a squamous cell carcinoma of the cervix.
The incidence of mixed carcinomas as proportion of all cancers is given in
Table I. The group of intact mice plus castrates given stilboestrol plus those
given thyroxine had only 3 per cent of mixed tumours while the castrates with
or without progestational treatment had 36 per cent, a statistically significant
difference of 33 + 8-73.
The total cervico-vaginal tumour incidence in the various groups did not differ
significantly though there were slightly fewer carcinomas in the castrates without
hormonal treatment. In most of the animals with carcinomas, papillomas were
also observed while an additional group ofmice had squamous papillomas but no
carcinomas. The incidence of carcinomas and papillomas for the various treat-
ment groups is given in Table II and in the histogram of Fig. 6 which shows
TABLE II.-Incidence of Carcinomas and ofAll Epithelial
Tumours at the Cervix
Percentage of
Number Epithelial
Treatment at risk Carcinomas tumours
DMBA
Intact. . . . . 17 76410-4 82+9i3
Castrate . . . 15 . 53±12-9 100±2 6
IV + Stilboestrol . 21 . 62±10-6 100±2-2
,, + Progesterone . 16 . 81+98 94±5 9
VP + Lutocyclin . . 16 . 75±10 8 100±2-5
,, + Eltroxin . 13 . 61±13-5 84±10-2
some variation in the proportion of carcinomas to papillomas with treatment.
The percentage of papillomas in intact mice was only 7 per cent but rose to 31
per cent (difference 24 ± 8.6) in castrates with or without additional treatment.
The proportion of carcinomas of all epithelial tumours (Table III) is significantly
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1l'ABLE II.-Proportiom- of Carcinona,s of 411 Epithelial
Tan/ours at the Cervix and Vulva
Cervix Vulva
r-~~~~~ A --.A
Nurher of Number of
tillnent tuniours () CarcinoInas ttuImlours /.
Intact
Castrate
,, ,- Stilboestiol
, +-- Progesterone
+ Lutocyclin .
. Eltroxinl
14
1 5
-21
135
16
11
93 6;- 8
.,3 12 '9
(i2 10*6
87 8 7
75 =10 8
73 - 13-4
11
15
19
14
8
12
Carcinoiiias
45±15-0
87±8 7
84±8-4
86±9*3
37+17 1
58±14-2
orreater in initact thain in castrate mice (differenice 40 ± 14.6), in intact than in
stilboestrol-treated castrates (difference 31 12.6) and in progesterone treated
castrates thain in castrated animals (difference :34 ± 15.5).
Timte ranges in tumnour induction
Since animals were killed only when there was definite clinical evidence of
cervico-vaginal tumours or wheni large vulval growths or other conditions made it
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necessary, the true induction time could not be determined. The duration from
the beginning oftreatment to (a) the histological verification ofthe first carcinoma
or papilloma, or (b) the time a 50 per cent incidence of tumours was reached can
be assessed from Fig. 7 and Table IV; the error in this time estimate is pre-
sumably similar in all treated groups. The variation in sensitivity of individual
mice is reflected in the S-type curves of Fig. 7 and makes the interval to first
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FIG. 7.-Cumulative percentage incidence of cervical carcinomas.
TABLE IV.-Induction Periodfor Cervical Tumours in Mice
Treatment
Intact mice
Castrate mice .
,, + Stilboestrol
,, + Progesterone
,, + Lutocyclin
, + Eltroxin
Strain
C3H
C3H
A
C3H
A
C3H
Interval in days to
appearance of
--I
Carcinomas Epithelial
tumours
First 50% 50%
168 205 200
126 180 140
85 201 175
150 166 166
98 135 128
80 164 145
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tumour appearance less reliable than the estimate of the induction time for a 50
per cent tumour incidence. Intact and stilboestrol treated castrate mice were
slowest to reach the 50 per cent level while those treated with Lutocyclin were the
fastest. A stilboestrol treated castrate mouse was one of the first to have a
histologically confirmed carcinoma, but the interval between the first cancer and
the 50 per cent level was the longest (116 days) while it was shortest for the
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FIG. 8.-The induction of papillomas and carcinomas at the cervix.
progesterone treated animals (16 days). The strain of mice did not markedly
affect the duration ofthe induction period and was ofthe same order for strain A
and C3H mice.
Though in the same mouse papillomas may precede the appearance of car-
cinomas, in some mice papillomas may appear at the same time as carcinomas do
in others, as Fig. 8 shows. The time for a 50 per cent incidence of all epithelial
tumours (carcinomas plus papillomas) is given in the last column ofTable IV and
shows some shortening as compared with carcinoma induction for castrate mice,
stilboestrol and Eltroxin treated castrates but no significant difference in the
other 3 groups.
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Tumour induction in the vulva
Although the vulva was blotted after painting to reduce the contamination
by the carcinogen, the majority of the treated animals showed hyperplasia of the
vulval epithelium which progressed to papillomas and carcinomas in a high pro-
portion of mice. The papillomas tended to precede and to coexist with the
carcinomas which were of the keratinising squamous cell type. Multiple carcin-
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FIG. 9.-The induction of papillomas and carcinomas at the vulva.
omas and papillomas were found in a great number ofvulvas in addition to hyper-
plastic regions.
Mice with vulval carcinomas were observed at the same time as others with
papillomas (Fig. 9). While the cumulative percentage ofmice with carcinomas rose
steeply, that ofmice with papillomas rose more slowly.
The incidence ofmice with carcinomas and those with papillomas only is given
in Table V and Fig. 10; there are significant differences between some of the
groups. The incidence of carcinomas in intact mice was 29 per cent and in cas-
trates 87 per cent (difference 58 + 14.0) and of all epithelial tumours 65 per cent
in intact and 100 per cent in castrate mice (difference 35 ± 11.8). This difference
is very likely real since Fig. 7 and 1I indicate a longer induction period for cervical
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TABLE V. Incidence of Carcinomas and of All Epithelial
Treatitient
Iintact .
Castrate
,, - Stilboestrol
,, --- Progesterone
l,uto(. clin
,, -t Eltroxiti
Tumours at the Vulva
-Number
at risk C
17
1)5
* )21
16
16;
13
Percentage of
Epithelial
arcinlomllas turnours
29V 11-0 65±11-6
87X 87 100±2 6
76 9-3 9146-62
75±l0 8 8748-4
19 -9 8 50 12 5
54 13 8 9217-5
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FIG. 10.- Histogramn showviIng the incidence of papillomas and earcinomas of the vulva after
different treatmiieints.
tumours and thus a longer survival time for initact than for castrate mice. Thus
in spite of more numerous exposures to DAIBA over a longer period of time, the
vulva of intact mice produced fewer tumours than that of the castrates. The
difference in incidence of carcinomas (Table A) in intact animals and in castrates
given stilboestrol is significant at the 95 per cent confidence level (difference
642
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47 ± 14.4), but the difference in the incidence of all epithelial tumours in these
two groups does not reach the same level of significance (difference 26 + 13.1).
The induction period for cervical tumours and the survival time for intact and
stilboestrol treated castrates (Fig. 7 and 11) is very similar.
The progesterone treated castrates had significantly more carcinomas than the
Lutocyclin treated group (difference 56 ± 14.6) and the difference in the incidence
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of all epithelial tumours (difference 37 ± 15.1), though smaller, is still significant.
The induction periodfor cervical tumours andwith it the survival time was shorter
in the Lutocyclin than in the progesterone treated mice (Fig. 7 and 11) and only
the longest survivors in the former group produced vulval tumours. The differ-
ence in vulval tumour incidence between these animals may thus be due to the
longer exposure to the carcinogen; it may also be influenced by genetic differences
in mouse strain.
The proportion of carcinomas of all epithelial tumours (Table III, Fig. 10) is
significantly greater in castrate than in intact mice (difference 42 ± 17-3) which is
..- - - -
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the reverse of that found for the cervix. The proportion of carcinomas is signi-
ficantly lower in the Lutocycin treated group than in the castrates and in the
progesterone treated animals (difference 50 + 19 1 and 49 ± 19-4 respectively).
A comparison ofFig. 7 and Fig. 11 shows less tendency for an S-type of curve
in the cumulative percentage of carcinomas at the vulva than for those at the
cervix. In particular the initial slope of the curve is much steeper at the vulva
than at the cervix.
Remote tumours and influence ofmoUse strain on tumour induction
In addition to tumours arising in the regions painted with DMBA, remote
growths occurred in the breast, the skin and as leukaemias. Adenocarcinomas of
cellular, papilliferous and cystic type were found in the breasts of C3H but not
TABLE VI.-Incidence ofRemote Tumours
Mice Skin
]'~~
A
Number Carci- Papil-
Treatment Strain at risk noma loma Breast Leukaemia
Intact mice . C3H 17 . 0 0 . 6 . 0
Castrate mice . . C3H 15 . 1 1 . 1 . 0
,, + Stilboestrol . A 21 0 9 . 0 . 0
,, + Progesterone C3H 16 . 1 0 . 2 4
,, + Lutocyclin . A 16 . 1 3 0 . 1
,, + Eltroxin . C3H 13 . 1 6 . 3 0
ofStrongAmice (TableVI). AmongtheC3H micetheyappeared mostfrequently
in the intact animals but this fact may be due to the longer induction period for
cervix tumours and thus to the longer survival time in this group. The effect of
castration on breast tumour induction is well known and the numbers in our
experiments are too small to allow ofany deductions about the effects ofthyroxin
and progesterone treatment.
Skin tumours were localised in the face, the mammary region from neck to
groin, the abdomen, thorax, legs and tail. The majority were papillomas (Table
VI) but 3 invasive carcinomas were found in 61 C3H and one in 37 Strong A mice.
These figures do not suggest any variation with strain in the incidence of skin
carcinomas. If, however, all 23 epithelial skin tumours are considered, the Strong
A mice are seen to have a significantly greater incidence (35 per cent) than the
C3H mice (15 per cent). The difference of 20 ± 9-1 is significant at the 95 per
cent confidence level.
Leukaemias were found in 5 of 32 mice treated with progesterone or Luto-
cycin but in none of the 66 mice treated in other ways. The significance of this
observation needs further investigation.
While breast tumours occurred in C3H mice only, skin tumours more fre-
quently in Strong A than in C3H mice, leukaemias seemed to be dependent on the
treatment rather than on the strain of mice. It is thus relevant to analyse how
far the results reported for the direct painting of the cervico-vaginal region and
the vulva in mice given additional systemic treatment are due to the trestments
rather than differences in the strain of mice used.
No significant difference between the various treatment groups was found in
the incidence of cervical carcinomas. Irrespective of treatment additional to
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the DMBA application the incidence of carcinomas at this site amounted to
69 per cent for 61 C3H mice and to 67 per cent for 37 of the Strong A strain.
The incidence for all epithelial tumours was 90 and 100 per cent respectively in
the two strains. The proportion of carcinomas among the epithelial tumours was
76 per cent for C3H and 67 per cent for Strong A mice and not significantly differ-
ent.
In the vulva the incidence of carcinomas was significantly lower in intact mice
and in the Lutocyclin group, the former ofwhich wereC3H andthelatterStrong A
mice. If both these groups are included, vulval carcinomas occurred in 60 per
cent of the C3H and in 51 per cent of the Strong A mice. If the two groups are
excluded the figures are 73 and 76 per cent respectively. The incidence of all
epithelial vulval tumours was 85 per cent for all C3H and 73 per cent for all mice
of the Strong A strain and changed to 93 and 91 per cent respectively after ex-
clusion of the intact and the Lutocyclin groups. The proportion of carcinomas as
percentage of all epithelial tumours at the vulva was 71 per cent for C3H and 70
per cent for Strong A animals and after exclusion of the two low incidence groups
changed to 78 and 84 per cent respectively.
There is thus no good evidence that the strain of mice determines the tumour
incidence in the vulva and cervix in the way it does that of breast cancers. In
Fig. 12 (a) and (b) the incidence of carcinomas and of all epithelial tumours at the
cervix and vulva are illustrated according to the experimental treatments. There
is comparatively little variation with treatment group in the incidence of cervical
epithelial tumours; this variation increases if carcinomas only are considered but
does not reach statistical significance. At the vulva too, the variation in the
incidence of carcinomas is greater than that of epithelial tumours particularly
for the intact C3H mice and for the Strong A Lutocyclin treated castrates.
There is no close correlation between the incidence of epithelial tumours at
the cervix and those of the vulva for the same treatment. The tumour yield at
the vulva is lower than that at the cervix, equals it or is even greater. The only
significant difference in the incidence ofepithelial tumours at the two sites is seen
in the Lutocycin treated group (Fig. 12 (b)). The differences in the yield of
carcinomas at the cervix and the vulva are greater and significant for 3 groups:
in intact mice and Lutocyclin treated castrates the cervical cancers are more
frequent than the vulval (difference 47 ± 15d1 and 56 ± 14-6 respectively)
while in castrates the vulval carcinomas are more numerous than the cervical
(differences 34 ± 15.5). While significantly more skin tumours are found in
Strong A than in C3H mice, no significant differences between the two strains are
seen in the incidence of tumours at the vulva which has essentially the same
structure as the skin in other parts. Murphy (1961) found no significant differ-
ences in the tumour yield and induction period at the cervix for C3H and Strong A
mice.
DISCUSSION
The most significant result of these investigations is the observation that in
castrate C3H and A mice with or without treatment with progestational hormones
the incidence ofmucoepidermal tumours is 36 per cent, while it is only 3 per cent
in intact C3H mice and castrate A and C3H animals treated with stilboestrol or
thyroxin (difference 33 ± 8.7). This suggests that hormonal influences can deter-
mine the histological type of a developing tumour, as was inferrred from the
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investigations on the types ofcervical cancers during and after pregnancy (Cherry
and Glucksmann, 1961). It is significant too that Murphy (1961) reports 3 muco-
epidermal tumours among 33 carcinomas in C57B1 castrate mice, but no such
mixed tumours among 101 cancers observed in C3H, A, C57B1 and strain 129
intact females or castrates given oestradiol. Scarpelli and v. Haam (1957) found
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FIG. 12 (a).-The incidence of carcinomas at the vulva and at the cervix after different
treatments.
one mucoepidermoid carcinoma among 72 carcinomas induced in C3H intact
females; Boyland, Charles and Gowing (1961) reported an unstated number of
mucoepidermal tumours among cervical cancers induced by carbowax, DMBA
and various spermicidal agents in stock mice. Barbieri, Olivi and Paoletti (1961)
diagnosed 7 mucoepidermal and 3 adenocarcinomas in the 34 cancers induced
in the cervix and uterus of 43 BALB mice by the intravaginal insertion ofthreads
coated with methylcholanthrene; the authors do not mention mucin secretion
in the mucoepidermoid tumours and may have based their diagnosis on an appar-
I
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ently columnar pattern of the tumours. Wachtel (1961), Koprowska et al.
(1958, 1959), Bogacz and Koprowska (1961), Reagan et al. (1955), Krieg and
Reagan (1961) and Klavins and Kaufman (1962) described only squamous cell
carcinomas in C3H mice treated with carcinogens. The last authors used oes-
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FIG. 12 (b).-The incidence ofepithelial tumours at the vulva and at the cervix after different
treatments.
tradiol benzoate in addition to methylcholanthrene in half of the intact females
and observed more highly differentiated tumours in the hormone treated mice.
All these findings suggest that at least in C3H and A mice after local applica-
tion of chemical carcinogens to the cervix, mucoepidermal tumours appear only
rarely in intact females, are not found in oestrogen treated castrate or intact
animals, but occur significantly more often in castrate mice and in castrates given
progestational hormones. The effect of the latter is to increase the extent of the
columnar component ratherthan the incidence ofmixed tumours found in castrate
mice. Whether the high incidence of mixed cervical carcinomas in the BALB
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mice is due to genetically-controlled hormonal factors or to other circumstances
remains to be investigated.
Obviously hormonal factors are not the only agents which determine the
differentiation of the cervico-vaginal epithelium. Vitamin A is known to inhibit
keratinisation of the mouse vagina grown in vitro (Lasnitzki, 1961) and irradiation
is found to counteract the effect of oestrogens on the vaginal epithelium of the
castrated rat (Cherry, 1957). Castration and progestational hormones have a
mucifying effect on the cervico-vaginal epithelium of mice but not all cancers
induced by chemical carcinogens in such animals are of mucoepidermoid type,
and furthermore, mixed squamous and columnar tumours rather than pure adeno-
carcinomas are found. This suggests the action of other factors which counteract
the effect ofcastration and ofprogestational hormones. The chemical carcinogens
used promote hyperplasia, stratification and cornification of the vagina and the
resulting differentiation of the vaginal epithelium during carcinogenesis will be
determined by the balance between this keratinising action and the mucifying
effect of castration and the progesterones.
In rodents the vaginal epithelium is known to have alternative potentialities
for cornification and mucification. In the human cervix the adjacent columnar
and squamous epithelia at the os histologicum may have such capabilities but
certainly are able to replace one another under suitable hormonal and other
stimulation. Carcinomas are known to arise from both sides of the squamo-
columnar junction but at least in the non-pregnant patient the squamous cell
carcinomas far out-number the adenocarcinomas and the mixed tumours. In
this respect the distribution of tumour types in mice and man are similar. The
increase in proportion ofmucoepidermal tumours in pregnant women with cervix
cancer resembles that found in castrate mice given progesterones, and in both
instances it is the mixed tumours rather than the adenocarcinomas that are
increased.
In our series of 98 mice only 1 sarcoma but 67 carcinomas and 25 papillomas
were induced in the cervix and vagina, while Murphy (1961) had 22 sarcomas and
152 carcinomas in 479 mice; Wachtel (1961) found 2 sarcomas and 14 carcinomas
in 17 mice, while no sarcomas were reported by Scarpelli and v. Haam (1957),
v. Haam and Scarpelli (1955), Koprowska et al. (1958), Bogacz and Koprowska,
(1961), Reagan et al. (1955). Pan and Gardner (1948) found 32 carcinomas and
29 sarcomas in 55 mice successfully grafted with subcutaneous implants of uterine
cervices and horns into which methylcholanthrene crystals had been inserted.
With this exception, the induced tumours in mice were predominantly epithelial
while in rats after intravaginal painting with DMBA the resulting tumours were
mainly sarcomas (Cherry and Glucksmann, 1960) though the insertion of DMBA-
impregnated threads into the cervices ofrats produced predominantly carcinomas
(Vellios and Griffin, 1957). Thus it seems that the method ofapplication of the
carcinogen determines to some extent whether sarcomas or carcinomas will be
produced, though a speciespredisposition for sarcomas in rats and for carcinomas
in mice seems to exist. Inaddition, at least inrats, the tendency for the induction
of carcinomas or sarcomas varies with the site treated; thus DMBA painting
produces mainly sarcomas in the vagina, carcinomas and sarcomas in the propor-
tion of 2-3 to 1 in the dorsal skin and 30 to 1 in the vulva.
Carcinomas may arise in papillomatous regions as well as in hyperplastic
areas and only a varying and often small proportion of papillomas progress to
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carcinomas. At the vulva as well as in the cervix and vagina, some animals had
only papillomas while others had carcinomas in addition to papillomas. For both
sites the proportion of papillomas to carcinomas is high when the incidence of
carcinomas is low or relatively low (Fig. 6 and 10). In the cervix and vagina the
increase in proportion of papillomas makes up for the lower incidence of car-
cinomas and the variations in the incidence of all epithelial tumours with the
different treatments is less than that for carcinomas only (Fig. 12 (a) and (b)).
At the vulva, on the other hand, the increase in proportion ofpapillomas does not
fully compensate for the smaller number ofcarcinomas and there is more variation
with treatment in the incidence of all epithelial tumours although this is less
marked than for carcinomas only. The total incidence of papillomas and car-
cinomas irrespective of treatment is somewhat lower at the vulva than at the
cervix (Fig. 8 and 9) but the general shape ofthe cumulative incidence curves and
the proportion of papillomas to carcinomas is very similar. This might suggest
that the site subjected to carcinogenic stimulation does not affect significantly the
progression ofpapillomas to carcinomas.
On the other hand, the type of treatment may influence the progression to
malignancy since significant differences in the proportion of papillomas to car-
cinomas are found in the various groups for the cervix and the vulva. On con-
sidering these differences attention must be paid to the duration of treatment
which varied in the individual groups because of differences in the induction time
for cervical tumours (Fig. 7). Although the difference in the proportion of car-
cinomas to papillomas of the cervix is significantly greater in intact than in
castrate mice, the duration of treatment and with it the dosage ofthe carcinogen
is also greater in the former than in the latter group. In the vulva the proportion
of carcinomas is greater in the castrate than in the intact animals in spite of the
shorter treatment period. Thus the significant difference between the two groups
in the proportion of malignant tumours at the cervix may be due to a dosage
factor rather than to a change in hormonal status, but this does not hold true
at the vulva. Even at the cervix this explanation does not account for all the
differences: for the same duration of treatment there are significantly more car-
cinomas than papillomas in the intact mice as compared with the stilboestrol
treated castrates, and in progesterone treated castrates than in the castrated mice.
Thus these differences must be ascribed to the changed endocrine state of the
animals. At the vulva significantly higher percentages of carcinomas (Table III)
are foundin castratesthaninintactmice as well as in Lutocyclintreated castrates,
and in progesterone treated as compared with Lutocyclin treated castrate animals.
Only in the first comparison (castrates: intacts) is the duration ofexposure to the
carcinogen longer for the group with the lower percentage of carcinomas, while
in the other two groups the lower proportion of carcinomas goes with the shorter
treatment period (Fig. 7 and 11). Thus for the vulva, in only one group is the
hormonal status responsible for the progression of carcinogenesis to the fully
malignant state, while the differences in the other groups may be due to the
different dosage ofDMBA.
The influence of dosage and effectiveness of the chemical carcinogens on
tumour yield and duration of induction period is seen in the experiments of
Murphy (1961), Scarpelli and v. Haam (1957) and Wachtel (1961) who report a
significant increase in tumour incidence and decrease in induction time ifmethyl-
cholanthrene was applied continuously on a thread than when it was applied
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intermittently by painting. Actually the duration of the induction period in our
experiments is only slightly longer for painting with DMBA than for the con-
tinuous action ofamethylcholanthrene impregnated thread inMurphy's, while the
tumour yield is of the same order. Thus the effect of the stronger carcinogen
DMBA in intermittent dosage is equivalent to that of the weaker methylchol-
anthrene in continuous dosage.
Carcinogenic dosage alone does not account for all the differences in tumour
vield in our experiments. In the intact mice and in the Lutocycin treated cas-
trates the incidence of cervical tumours is high and of the same order while that
ofvulval tumours is low and again about equal in the two groups. The duration
of exposure to the DMBA was longer and thus the dosage greater in the intact
mice than in the Lutocycin group. Thus Lutocycin increasedthereactivityofthe
cervix to the action of DMBA but failed to do so at the vulva. On the other
hand, castration increased the response ofthe vulva to DMBA but not that ofthe
cervix as seen by the difference in yield of tumours at the two sites. It seems,
therefore, that the effect ofhormonal status on response to carcinogens varies with
the organ.
The effect on tumour yield of the different treatments is much smaller in mice
than in rats (Cherry and Glucksmann, 1960). There was little difference in
tumour yield when rats were painted with benzopyrene in acetone in dioestrus
or at the peak of oestrus (Stein-Werblowsky, 1960). In the experiments on rats
oestradiol and stilboestradiol had little effect on the incidence of tumours while
in mice Murphy (1961) and Krieg and Reagan (1961) report some striking effects
if the carcinogenic dosage is reduced. In our experiments in mice using a high
carcinogenic dose, the effect is not strikingly different at the cervix or the vulva
in castrates with and without additional stilboestrol treatment.
The vulva and the cervix of mice seem to differ in their susceptiblity to car-
cinogenic treatment: the incidence of all epithelial tumours is similar at the two
sites or significantly lower at the vulva, while the incidence ofcarcinomas is signi-
ficantly higher at the cervix thanthevulva intheintactandtheLutocyclintreated
animals and the reverse holds true for castrate mice. This may be due to un-
avoidable differences in the carcinogenic dosage of the cervix and the "blotted "
vulva. The vulva may be very sensitive to slight contamination by carcinogens
since Murphy (1961) reports papillomas and some invasive tumours on the vulva
in mice treated with methylcholanthrene threads inserted into the cervical canal
for only 4 weeks.
Neither our results nor those ofMurphy suggest a marked difference between
the C3H and A strain on the induction period, number or type of tumours in-
duced in the female genital tract; but the results ofBarbieri et al. (1961) suggest
that the BALB strain may differ from the A and C3H strains at least as far as
tumour type is concerned. In Japan, Oota and Tanaka (1954) report that 33
per cent ofall early tumours ofthe cervix have a columnar component irrespective
of pregnancy, a figure very significantly greater than that found in European
women with cancer of the cervix. The significance of these reports cannot be
assessed without further information about the hormonal status of these mice
and women.
SUMMARY
The effect of castration and of castration followed by medication with stil-
boestrol, progesterone, Lutocyclin andthyroxin on the induction period, type and
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number of cervical and vulval tumours in C3H and A mice treated by weekly
paintings ofDMBA was investigated.
Ovariectomy significantly increased the incidence of mucoepidermoid car-
cinomas ofthe cervix. Treatment ofcastrate mice withprogesterone or with Luto-
cyclinincreased the extent ofthe adenocarcinomatous componentofthesetumours,
while stilboestrol treatment resulted in the induction of squamous cell carcinomas
only.
The percentage of papillomas of all epithelial tumours in the cervix of intact
mice was only 7 per cent but rose to 31 per cent in castrates with or without
additional hormonal treatment.
Castration with or without additional hormonal treatment had little influence
on the tumour incidence in the cervix, but caused significant differences in the
incidence of vulval papillomas and carcinomas. In spite of a longer treatment
period the tumour yield at the vulva of intact mice was markedly lower than in
castrates.
No influence of mouse strain on the incidence of cervical and vulval tumours
was found. Skin papillomas occurred more frequently in A than in C3H mice,
breast tumours only in C3H mice and leukaemias in castrate A and C3H mice
treated with progestational hormones.
The effect of castration and additional hormonal treatment produced different
effects on the carcinogenesis in the vulva and the cervix.
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